Company Profile

Vivesto AB (OTC: OASMY)
1:56 PM UTC, 05/08/24
Last: $0.05 Change: +0.03 %Change: +149.50% Volume: 1,700
Detailed Quote
Open: $ 0.05   Volume: 1,700
High: $ 0.05   Yield(%) 0.00
Low: $ 0.05   P/E Ratio (ttm): n/a
Dividend ($): 0.00   Market Cap ($): 8.97M
EPS ($) -0.06   Shares Out: 179.35M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 0.00
% Price Change (last 13 weeks): 149.50
% Price Change (last 26 weeks): 149.50
% Price Change (last 52 weeks): -37.10
% Price Change (year to date): 150.00
Management Effectiveness
Return on Equity (%): -47.69
Return on Assets (%): -43.27
Return on Invested Capital (%): -48.12
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $0.05
52-wk low: $0.000
Bid: $n/a
Ask: $n/a
Company Information
Vivesto AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand in 1999 and is headquartered in Solna, Sweden.
Vivesto AB
P. O. Box 3061
Solna AB 169 03

Phone: 46.18.50.54.40
Fax: 46.18.51.08.73
http://www.oasmia.com
Per Share Data
Earnings (1year) ($): -0.06
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.11
Cash Flow ($): -0.07
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 0.18
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 3.51
Current Ratio (x): 3.51
LT Debt/Equity (x): 0.00
Total Debt/Equity (x): 0.00



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.